Skip to main content

Blinatumomab



General

Pronunciation

(blin a TOOM oh mab)

Brand Names: U.S.

  • Blincyto

Indications

Use: Labeled Indications

Acute lymphoblastic leukemia, minimal residual disease–positive (CD19-positive): Treatment of CD19-...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×